Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Biomedicines|May 27, 2023
Prognostic Value of Spot Urinary Creatinine Concentration and Its Relationship with Body Composition Parameters in HF PatientsJolanta Malinowska-Borowska, Małgorzata Piecuch, Patryk Szlacheta, et al.
Kardiologia Polska|March 4, 2015
Periprocedural checklist in the catheterisation laboratory is associated with decreased rate of treatment complicationsMichał Hawranek, Paweł M Gąsior, Piotr Buchta, et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|February 7, 2022
Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathyMichał Hawranek, Łukasz Pyka, Bożena Szyguła-Jurkiewicz, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 29, 2023
Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and MortalityŁukasz Pyka, Bartosz Hudzik, Stanisław Bartuś, et al.
Platelets|March 5, 2016
Prognostic implications of mean platelet volume on short- and long-term outcomes among patients with non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: A single-center large observational studyJarosław Wasilewski, Piotr Desperak, Michał Hawranek, et al.
Annals of Transplantation|April 8, 2020
Everolimus-Eluting Second-Generation Stents for Treatment of De Novo Lesions in Patients with Cardiac Allograft VasculopathyŁukasz Pyka, Michał Hawranek, Bożena Szyguła-Jurkiewicz, et al.
Polskie Archiwum Medycyny Wewnetrznej|March 19, 2016
Prognostic value of neutrophil‑to‑lymphocyte ratio in predicting long-term mortality in patients with ischemic and nonischemic heart failureJarosław Wasilewski, Łukasz Pyka, Michał Hawranek, et al.
Clinics and Practice|September 26, 2025
Implantable Cardioverter-Defibrillator Therapies Following Generator Replacements-Long-Term Remote Monitoring DataMaciej Dyrbuś, Łukasz Pyka, Anna Kurek, et al.
Kardiologia Polska|November 25, 2015
COnteMporary Modalities In Treatment of Heart Failure: a report from the COMMIT-HF registryMariusz Gąsior, Łukasz Pyka, Jarosław Gorol, et al.
Cardiology Journal|October 14, 2016
Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registryMateusz Tajstra, Elżbieta Gadula-Gacek, Anna Kurek, et al.
Pageof 4